1. Division of Toxicology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands;
2. TI Pharma, Leiden, The Netherlands;
3. Medicinal Safety Research Laboratories, Daiichi Sankyo Co. Ltd, Tokyo, Japan;
4. Bioceros, Utrecht, The Netherlands;
5. Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands